Roswell Park Researcher Receives $1.2 Million To Study Cancer Immunology

 10.07.2008 06:16   medicalnewstoday.com

Peter Demant, MD, PhD, Distinguished Member, Department of Molecular and Cellular Biology at Roswell Park Cancer Institute (RPCI), has been awarded a four-year, $1.2 million grant from the National Cancer Institute (NCI) to evaluate how an individual's genes impact his/her immune response to cancer. Dr. Demant and his RPCI colleagues recently mapped novel genes that determine the intensity of the immune response to cancer in each patient.

World Cancer